Health

Health
U.S. overdose deaths topped 100,000 in one year, officials say
U.S. health officials say an estimated 100,000 Americans died of drug overdoses in one year. That's a total the nation has never seen. Experts say it's tied to the COVID-19 pandemic and a more dangerous drug supply.
Defense Department will help relieve 2 Minnesota hospitals
Gov. Tim Walz says the Department of Defense will send medical teams to two major Minnesota hospitals to relieve doctors and nurses who’ve been swamped by a growing wave of COVID-19 patients.
What's next for Minnesota's COVID surge?
Host Cathy Wurzer talked about COVID-19 modeling with Curtis Storlie, a health science researcher at Mayo Clinic.
COVID disconnect? As cases climbed, Minnesotans dropped their guard, officials say
Minnesota has hit COVID-19 case numbers not seen since last winter and dozens are still dying of the virus every week. And yet health officials say many people are behaving as if the pandemic isn’t a threat.
U.S. COVID cases start to rise again as the holidays approach
After declining most of the fall, new infections are up again in more than half of U.S. states, worrying experts about what the holiday season may bring.
Disrupting domestic violence
Violence in the home increased during the pandemic. Why? What can be done? MPR News host Angela Davis talks with violence prevention advocates who help survivors heal and abusers change. 
COVID-19 in MN: State readies booster push; hospital needs, deaths climb
With case counts at or near their highest levels since December, Minnesota intends to move ahead this week to offer vaccine booster shots to any eligible Minnesotan who wants one, the state’s health commissioner said Tuesday.
Cost of providing health care for many Minnesotans declined in 2020
For the first time in several years, the total year-over-year cost of providing health care for Minnesotans with private insurance decreased, and the pandemic likely was the biggest factor.
Pfizer agrees to let other companies make its COVID-19 pill
Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world's population.